A B S T R A C T The metabolic disposition of the plasma binding protein (DBP) for vitamin D and its metabolites was studied in adult rabbits. Apo-DBP was purified from rabbit plasma and enzymatically labeled with radioiodine. The radioiodine-labeled protein retained its ability to bind vitamin D sterols and its physicochemical properties. When 125I-labeled DBP and '3II-labeled rabbit albumin were simultaneously injected intravenously, the 1251 was cleared from plasma at a faster rate (t1/2 = 1.7 d) than 131I (tl/2 = 5 d) and 125I was present in excess of 131I in kidney, liver, skeletal muscle, heart, lung, intestine, testis, and bone 1 h after injection. In contrast to DBP, 25(OH)D3 was cleared more slowly (t1/2 = 10.7 d). Compared to albumin, DBP radioactivity appeared earlier and in greater quantity in the urine ofcatheterized rabbits. Gel filtration analyses of plasma revealed most of the 1251 to elute in the position of DBP, with only small amounts in the <1,000-dalton region. In contrast, almost all of the urine 1251 eluted in this small molecular weight fraction. The molar ratio of DBP to 25(OH)D3 in normal rabbit plasma was 138/1. The extravascular pool of DBP was calculated to be 1.5-2.4 times larger than the intravascular DBP pool, and the molar replacement rate of DBP was 1,350-fold higher than that for 25(OH)D3. The plasma disappearance curves of holo-DBP, prepared either by saturating with 25(OH)D3 or by covalently linking 3,8-bromoacetoxy-25(OH)D3, were very similar to that of apo-DBP. Neuraminidase treatment of DBP did not alter its plasma survival.These studies indicate that DBP or DBP-25(OH)D3 complex is removed from plasma by a variety oftissues, that the DBP moiety is degraded during this process, This work was carried out during Dr. Haddad's tenure as a recipient of a Josiah Macy, Jr. Foundation Faculty Scholar Award (1978-1979